Self-expanding metal stenting for obstructing left colon cancer: A district hospital experience

2016 ◽  
Vol 35 (4) ◽  
pp. 305-309
Author(s):  
Mohan Raj Harilingam ◽  
Amjad Khushal ◽  
Abdulmalik Aikoye
Keyword(s):  
Colon Cancer ◽  
District Hospital ◽  
Left Colon ◽  
Hospital Experience ◽  
Left Colon Cancer

scholarly journals Congestive ischemic colitis occurring after resection of left colon cancer: 4 case series

2020 ◽  
Vol 6 (1) ◽  
Author(s):  
Takatsugu Fujii ◽  
Shigeo Toda ◽  
Yuki Nishihara ◽  
Yusuke Maeda ◽  
Kosuke Hiramatsu ◽  
...  
Keyword(s):  
Colon Cancer ◽  
Ischemic Colitis ◽  
Case Series ◽  
Left Colon ◽  
Left Colon Cancer

Quality of Life in Patients with Right or Left Colon Cancer

2008 ◽  
Vol 61 (7) ◽  
pp. 378-383
Author(s):  
Akira Tsunoda ◽  
Kazuhiro Narita ◽  
Makoto Watanabe ◽  
Nobuaki Matsui ◽  
Koji Takenaka ◽  
...  
Keyword(s):  
Quality Of Life ◽  
Colon Cancer ◽  
Left Colon ◽  
Left Colon Cancer

Right versus left Colon cancer: Is there a difference in outcomes?

2019 ◽  
Vol 8 (1) ◽  
pp. 14
Author(s):  
JosephW Nunoo-Mensah ◽  
Aris Plastiras ◽  
Evangelia Iosif ◽  
Georgia Georgiou ◽  
Amyn Haji ◽  
...  
Keyword(s):  
Colon Cancer ◽  
Left Colon ◽  
Left Colon Cancer

scholarly journals Clinicopathological and outcome differences between right and left colon cancer: An institutional experience from South India

2017 ◽  
Vol 28 ◽  
pp. x50-x51
Author(s):  
R. Kandula ◽  
S. Gundeti ◽  
K. Rajesh ◽  
A. Ravishankar ◽  
B. Stalin ◽  
...  
Keyword(s):  
Colon Cancer ◽  
South India ◽  
Left Colon ◽  
Institutional Experience ◽  
Outcome Differences ◽  
Left Colon Cancer

Right Versus Left Colon Cancer: Resectable and Metastatic Disease

2018 ◽  
Vol 19 (6) ◽  
Author(s):  
Michele Ghidini ◽  
Fausto Petrelli ◽  
Gianluca Tomasello
Keyword(s):  
Colon Cancer ◽  
Metastatic Disease ◽  
Left Colon ◽  
Left Colon Cancer

scholarly journals Whether regional lymph nodes evaluation should be equally required for both right and left colon cancer

Oncotarget ◽  
2016 ◽  
Vol 7 (37) ◽  
pp. 59945-59956 ◽  
Author(s):  
Xu Guan ◽  
Wei Chen ◽  
Zheng Liu ◽  
Zheng Jiang ◽  
Hanqing Hu ◽  
...  
Keyword(s):  
Colon Cancer ◽  
Lymph Nodes ◽  
Left Colon ◽  
Regional Lymph Nodes ◽  
Left Colon Cancer

Outcome comparison between bridge to surgery stenting and emergency surgery in stage II, III obstructive left colon cancer: A multicenter retrospective study.

2016 ◽  
Vol 34 (4_suppl) ◽  
pp. 747-747
Author(s):  
Han-mo Yoo ◽  
Won-Kyung Kang
Keyword(s):  
Colon Cancer ◽  
Emergency Surgery ◽  
Disease Free Survival ◽  
Left Colon ◽  
Stage Ii ◽  
Stage Iii ◽  
Free Survival ◽  
Sems Group ◽  
Left Colon Cancer ◽  
Disease Free

747 Background: A SEMS (Self Expandable Metallic Stents) has been widely used for obstructive colorectal cancer as a bridge to surgery to avoid emergency surgery. However, it may increase the tumor spillage so that the long-term survival would be compromised. The aim of our study was to compare the short- and long-term outcome of surgery after stent insertion with those of emergency surgery alone for the left colon malignant obstruction patients. Methods: The medical records of patients who received curative resection due to obstructive primary left colon cancer and diagnosed to stage II or III from January 2004 to December 2010 in six hospitals affiliated to the Catholic Medical Center. Overall survival and disease free survival were compared between the SEMS (n = 158) and emergency surgery (n = 56) group. Short-term outcome was also compared. Factors affecting disease-free survival in the SEMS group were analyzed using the cox proportional hazards model. Results: Baseline characteristics were comparable between two groups by pathologic stage. Intra-operative complication (0.0% vs. 7.1%, p = 0.004), re-operation (1.3% vs. 7.1%, p = 0.042), post-operative hospital stay (11.2 ± 6.5 days vs. 14.6 ± 8.9 days, p = 0.010) and conversion rate (3.5% vs. 16.7%, p = 0.028) showed short-term advantages of the SEMS. 5-year DFS in stage II patients was 87.2% for the SMES group, 73.5% for the ES group (p = 0.117). Among stage III patients, 5-year DFS was 55.8% for the SEMS group and 72.0% for the ES group (p = 0.129). 5-year OS of the SEMS group was 90.2%, and of the ES group was 92.4% in stage II patients (p = 0.694). 5-year OS in the SEMS group was 82.8%, and the ES group 73.0% in stage III patients (p = 0.577). For the stage III SEMS patients, hospital of procedure (p = 0.041) and operation date (HR 0.400, 95% C.I 0.176-0.905, p = 0.028) were independent factors on disease free survival. Conclusions: If there’s an intervention team with sufficient experience for the SEMS and a sufficient preparation for emergency surgery, the SEMS is a good therapeutic option for malignant obstruction in left colon cancer.

Sign in / Sign up

Export Citation Format

Share Document